Maryland CC Project Law: Hemophagocytic Lymphohistiocytosis, a critical care conundrum!
15 snips
Nov 9, 2016 Jennie Y. Law, an Assistant Professor of Medicine at the University of Maryland, dives deep into Hemophagocytic Lymphohistiocytosis (HLH), unraveling its complexities. She discusses the critical importance of recognizing symptoms early and the challenges in diagnosing HLH in adult patients. Key insights include the HLH 2004 criteria versus the newer HSCORE, treatment algorithms derived from pediatric trials, and the impact of ferritin levels on prognosis. Law emphasizes the need for collaboration in critical care to improve patient outcomes.
AI Snips
Chapters
Transcript
Episode notes
Four Fatal Adult HLH Cases
- Dr. Jennie Y. Law described four recent adult HLH cases, all presenting critically ill with ferritin >50,000.
- Each case had varied triggers and treatments but all ultimately died, underscoring high early mortality.
Mechanism: Failed Cytotoxic Regulation
- HLH is excessive immune activation from failure to downregulate activated macrophages and cytotoxic lymphocytes.
- Impaired perforin-mediated cytotoxicity prevents elimination of activated macrophages leading to organ damage.
Genetics Drive Primary HLH Decisions
- Primary HLH often stems from autosomal recessive defects in perforin-related genes requiring an infectious trigger.
- Identifying genetic mutations guides transplant need, recurrence risk, and family counseling.